Brazil Unveils First Drug-Tracking Platform October 21, 2014 The system must be fully adopted by 2016. Read More
Reprogenetics, Illumina Team Up to Use Next-Gen Sequencing Technology for Infertility October 20, 2014 The companies will develop in vitro fertilization technologies. Read More
Celegene’s Multiple Myeloma Drug Imnovid Rejected by NICE October 20, 2014 Imnovid did not show superiority over either Revlimid or Velcade. Read More
Boston Scientific Gets CE Mark for MRI-Compatible Pacemakers October 17, 2014 When used with the company’s Ingevity leads, Accolade pacemakers allow patients to receive full-body MRI scans. Read More
Millennium’s Cancer Drug Velcade Scores Another New Indication October 17, 2014 It can now be used to treat patients with mantle cell lymphoma. Read More
Natus Medical Launches Combined Ultrasound-EMG System October 16, 2014 The Vista Ultrasound system will be available as an add-on to existing systems and with all new ones. Read More
Gilead’s New Hep C Treatment Gets FDA Approval October 16, 2014 The approval boosts the company’s already robust hepatitis C portfolio. Read More
First Patient Implanted With InVivo’s Spinal Scaffold October 15, 2014 The scaffold is for treating complete traumatic spinal cord injuries. Read More
Chimerix’s Ebola Drug to See Clinical Trials October 15, 2014 The FDA last week approved the company’s emergency investigational NDA. Read More
BD Picks Up NGS Technology Firm GenCell Biosystems October 14, 2014 The move gains BD entry into the next-generation sequencing market. Read More
Regeneron’s Eye Injection Eylea Gets New Indication October 14, 2014 The expanded indication will cover macular edema following branch retinal vein occlusion. Read More
ClearFlow Announces Positive Results from its PleuraFlow System Trial October 13, 2014 The device reduces bleeding that occurs after heart surgery. Read More